419 related articles for article (PubMed ID: 35413821)
21. Identification of glioblastoma gene prognosis modules based on weighted gene co-expression network analysis.
Xu P; Yang J; Liu J; Yang X; Liao J; Yuan F; Xu Y; Liu B; Chen Q
BMC Med Genomics; 2018 Nov; 11(1):96. PubMed ID: 30382873
[TBL] [Abstract][Full Text] [Related]
22. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples.
Mukherjee S
Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845
[TBL] [Abstract][Full Text] [Related]
23. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
Liu J; Xu K; Ma L; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
[TBL] [Abstract][Full Text] [Related]
24. Integrated Analysis to Evaluate the Prognostic Value of Signature mRNAs in Glioblastoma Multiforme.
Yang J; Wang L; Xu Z; Wu L; Liu B; Wang J; Tian D; Xiong X; Chen Q
Front Genet; 2020; 11():253. PubMed ID: 32296458
[TBL] [Abstract][Full Text] [Related]
25. Screening of key immune
Huang Y; Wang A; Wang F; Xu Y; Zhang W; Shi F; Wang S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):207-219. PubMed ID: 38755717
[TBL] [Abstract][Full Text] [Related]
26. Gene regulation network analysis reveals core genes associated with survival in glioblastoma multiforme.
Jiang L; Zhong M; Chen T; Zhu X; Yang H; Lv K
J Cell Mol Med; 2020 Sep; 24(17):10075-10087. PubMed ID: 32696617
[TBL] [Abstract][Full Text] [Related]
27. Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma.
Yin W; Tang G; Zhou Q; Cao Y; Li H; Fu X; Wu Z; Jiang X
Front Genet; 2019; 10():419. PubMed ID: 31130992
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of HOXD3 and UNC5C as molecular signatures in keloid based on weighted gene co-expression network analysis.
Wang H; Zhou Z; Liu Y; Wang P; Chen L; Qi S; Xie J; Tang J
Genomics; 2022 Jul; 114(4):110403. PubMed ID: 35709926
[TBL] [Abstract][Full Text] [Related]
29. Integrative analysis of DNA methylation and gene expression profiles to identify biomarkers of glioblastoma.
Alivand MR; Najafi S; Esmaeili S; Rahmanpour D; Zhaleh H; Rahmati Y
Cancer Genet; 2021 Nov; 258-259():135-150. PubMed ID: 34773808
[TBL] [Abstract][Full Text] [Related]
30. Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysis.
Wu YP; Ke ZB; Lin F; Wen YA; Chen S; Li XD; Chen SH; Sun XL; Huang JB; Zheng QS; Xue XY; Wei Y; Xu N
Pathol Res Pract; 2020 Oct; 216(10):153109. PubMed ID: 32853947
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatics analysis of potential core genes for glioblastoma.
Zhang Y; Yang X; Zhu XL; Hao JQ; Bai H; Xiao YC; Wang ZZ; Hao CY; Duan HB
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32667033
[TBL] [Abstract][Full Text] [Related]
32. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
[TBL] [Abstract][Full Text] [Related]
33. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
34. Identification of key modules and hub genes in glioblastoma multiforme based on co-expression network analysis.
Li C; Pu B; Gu L; Zhang M; Shen H; Yuan Y; Liao L
FEBS Open Bio; 2021 Mar; 11(3):833-850. PubMed ID: 33423377
[TBL] [Abstract][Full Text] [Related]
35. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
[TBL] [Abstract][Full Text] [Related]
36. In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.
Xiong DD; Xu WQ; He RQ; Dang YW; Chen G; Luo DZ
Oncol Rep; 2019 Apr; 41(4):2194-2208. PubMed ID: 30816530
[TBL] [Abstract][Full Text] [Related]
37. Identification of Biomarkers Associated With CD8+ T Cells in Coronary Artery Disease and Their Pan-Cancer Analysis.
Zhao S; Wu Y; Wei Y; Xu X; Zheng J
Front Immunol; 2022; 13():876616. PubMed ID: 35799780
[TBL] [Abstract][Full Text] [Related]
38. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
Wu M; Sun Y; Wu J; Liu G
Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
[TBL] [Abstract][Full Text] [Related]
39. Identification of Tumor Antigens and Immune Subtypes of Glioblastoma for mRNA Vaccine Development.
Lin H; Wang K; Xiong Y; Zhou L; Yang Y; Chen S; Xu P; Zhou Y; Mao R; Lv G; Wang P; Zhou D
Front Immunol; 2022; 13():773264. PubMed ID: 35185876
[TBL] [Abstract][Full Text] [Related]
40. Integrated analysis of single-cell sequencing and weighted co-expression network identifies a novel signature based on cellular senescence-related genes to predict prognosis in glioblastoma.
Bao Q; Yu X; Qi X
Environ Toxicol; 2024 Feb; 39(2):643-656. PubMed ID: 37565732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
